Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome

Background Gastric cancer remains a serious health concern worldwide. Patients would greatly benefit from the discovery of new biomarkers that predict outcome more accurately and allow better treatment and follow-up decisions. Here, we used a retrospective, observational study to assess the expressi...

ver descrição completa

Detalhes bibliográficos
Autor principal: Camilo, Vânia (author)
Outros Autores: Barros, Rita (author), Celestino, Ricardo (author), Castro, Patrícia (author), Vieira, Joana (author), Teixeira, Manuel (author), Carneiro, Fatima (author), Pinho de Sousa, João (author), David, Leonor (author), Almeida, Raquel (author)
Formato: article
Idioma:eng
Publicado em: 2015
Assuntos:
SOX2
CDX2
Gastric cancer
Prognosis
Survival
Texto completo:http://hdl.handle.net/10400.22/5390
País:Portugal
Oai:oai:recipp.ipp.pt:10400.22/5390

Texto Completo

http://hdl.handle.net/10400.22/5390

Registros relacionados